Mixed (multiple-genotype) Helicobacter pylori infections in Bulgarian patients.


Journal

Diagnostic microbiology and infectious disease
ISSN: 1879-0070
Titre abrégé: Diagn Microbiol Infect Dis
Pays: United States
ID NLM: 8305899

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 20 06 2023
revised: 22 08 2023
accepted: 24 08 2023
medline: 13 11 2023
pubmed: 17 9 2023
entrez: 17 9 2023
Statut: ppublish

Résumé

The aim of the study was to evaluate the frequency and characteristics of mixed (multiple-genotype) Helicobacter pylori infections (MGIs) in 155 Bulgarian symptomatic patients (21 children and 134 adults). MGIs were common (36.1%), including double-strain (34.8%) and triple-strain infections (1.3%). None of the 8 ulcer patients harbored multiple subtypes. We detected 18 multiple allelic combinations, of which the most frequent subtypes (17.4%) were vacA s1as2 and vacA s1cs2. The 2 patients with triple-strain infections had vacA s1bs1cs2i1i2/iceA1A2 and vacA s1as1cs2 subtypes. They were both adult men with chronic gastritis and both were examined in 2022. The prevalence of MGIs (51.7%) was 2-fold higher in 2020 to 2022 than in 2015 to 2019 (26.3%). Putative factors for the increase may be the patient's characteristics and COVID-19 pandemic-associated factors. MGI rates corresponded to the high infection seroprevalence (72.4% in 2011) in Bulgaria. The evolution and clinical importance of mixed H. pylori infections merit extensive evaluation.

Identifiants

pubmed: 37717293
pii: S0732-8893(23)00182-7
doi: 10.1016/j.diagmicrobio.2023.116073
pii:
doi:

Substances chimiques

Bacterial Proteins 0
Antigens, Bacterial 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

116073

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Lyudmila Boyanova (L)

Department of Medical Microbiology, Medical Faculty, Medical University of Sofia, Sofia, Bulgaria. Electronic address: l.boyanova@hotmail.com.

Liliya Boyanova (L)

Department of Medical Microbiology, Medical Faculty, Medical University of Sofia, Sofia, Bulgaria.

Petyo Hadzhiyski (P)

Specialized Hospital for Active Pediatric Treatment, Medical Faculty, Medical University of Sofia, Sofia, Bulgaria.

Nayden Kandilarov (N)

Department of General and Hepatobiliary Pancreatic Surgery, Department of Surgery, Medical Faculty, Medical University of Sofia, Sofia, Bulgaria.

Daniel Yordanov (D)

Department of Medical Microbiology, Medical Faculty, Medical University of Sofia, Sofia, Bulgaria.

Raina Gergova (R)

Department of Medical Microbiology, Medical Faculty, Medical University of Sofia, Sofia, Bulgaria.

Rumyana Markovska (R)

Department of Medical Microbiology, Medical Faculty, Medical University of Sofia, Sofia, Bulgaria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH